Hepatitis C Virus Variants with Decreased Sensitivity to Direct-Acting Antivirals (DAAs) Were Rarely Observed in DAA-Naive Patients prior to Treatment
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hepatitis C Virus Variants with Decreased Sensitivity to Direct-Acting Antivirals (DAAs) Were Rarely Observed in DAA-Naive Patients prior to Treatment
Authors
Keywords
-
Journal
JOURNAL OF VIROLOGY
Volume 87, Issue 3, Pages 1544-1553
Publisher
American Society for Microbiology
Online
2012-11-15
DOI
10.1128/jvi.02294-12
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ketoamide Resistance and Hepatitis C Virus Fitness in Val55 Variants of the NS3 Serine Protease
- (2012) Christoph Welsch et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Resistance to mericitabine, a nucleoside analogue inhibitor of HCV RNA-dependent RNA polymerase
- (2012) Jean-Michel Pawlotsky et al. ANTIVIRAL THERAPY
- Efficacy of Re-treatment With TMC435 as Combination Therapy in Hepatitis C Virus–Infected Patients Following TMC435 Monotherapy
- (2012) Oliver Lenz et al. GASTROENTEROLOGY
- Impact of a baseline polymorphism on the emergence of resistance to the hepatitis C virus nonstructural protein 5a replication complex inhibitor, BMS-790052
- (2012) Jin-Hua Sun et al. HEPATOLOGY
- Abundant Drug-Resistant NS3 Mutants Detected by Deep Sequencing in Hepatitis C Virus-Infected Patients Undergoing NS3 Protease Inhibitor Monotherapy
- (2012) E. S. Svarovskaia et al. JOURNAL OF CLINICAL MICROBIOLOGY
- 1184 CHARACTERIZATION OF HCV VARIANTS IN GENOTYPE 1 TREATMENT-NAIVE PATIENTS ADMINISTERED THE COMBINATION OF TVR AND VX-222 IN DUAL ARMS OF ZENITH STUDY
- (2012) E.Z. Zhang et al. JOURNAL OF HEPATOLOGY
- 1113 ELECTRON: ONCE DAILY PSI-7977 PLUS RBV IN HCV GT1/2/3
- (2012) E.J. Gane et al. JOURNAL OF HEPATOLOGY
- Hepatitis C Viral Evolution in Genotype 1 Treatment-Naïve and Treatment-Experienced Patients Receiving Telaprevir-Based Therapy in Clinical Trials
- (2012) Tara L. Kieffer et al. PLoS One
- Characterization of Resistance to the Nonnucleoside NS5B Inhibitor Filibuvir in Hepatitis C Virus-Infected Patients
- (2011) Philip J. F. Troke et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of the Protease Inhibitor BI 201335, Polymerase Inhibitor BI 207127, and Ribavirin in Patients With Chronic HCV Infection
- (2011) Stefan Zeuzem et al. GASTROENTEROLOGY
- Retreatment with telaprevir combination therapy in hepatitis C patients with well-characterized prior treatment response
- (2011) Andrew J. Muir et al. HEPATOLOGY
- Treatment failure and resistance with direct-acting antiviral drugs against hepatitis C virus
- (2011) Jean-Michel Pawlotsky HEPATOLOGY
- 1225 CHARACTERIZATION OF VIRAL RESISTANCE MUTATIONS IN GENOTYPE 1 HCV PATIENTS RECEIVING COMBINATION THERAPY WITH A PROTEASE INHIBITOR AND A POLYMERASE INHIBITOR WITH OR WITHOUT RIBAVIRIN
- (2011) H. Mo et al. JOURNAL OF HEPATOLOGY
- Hepatitis C Virus Nucleotide Inhibitors PSI-352938 and PSI-353661 Exhibit a Novel Mechanism of Resistance Requiring Multiple Mutations within Replicon RNA
- (2011) A. M. Lam et al. JOURNAL OF VIROLOGY
- Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection
- (2011) Kenneth E. Sherman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Retreatment of HCV Infection
- (2011) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
- (2011) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Contribution of a mutational bias in hepatitis C virus replication to the genetic barrier in the development of drug resistance
- (2011) M. H. Powdrill et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Resistance Analysis of the Hepatitis C Virus NS5A Inhibitor BMS-790052 in an In Vitro Replicon System
- (2010) R. A. Fridell et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Resistance Profile of the Hepatitis C Virus NS3/4A Protease Inhibitor TMC435
- (2010) O. Lenz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Susceptibility of Treatment-Naive Hepatitis C Virus (HCV) Clinical Isolates to HCV Protease Inhibitors
- (2010) A. Bae et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Telaprevir for Previously Treated Chronic HCV Infection
- (2010) John G. McHutchison et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Multi-Variant, Viral Dynamic Model of Genotype 1 HCV to Assess the in vivo Evolution of Protease-Inhibitor Resistant Variants
- (2010) Bambang S. Adiwijaya et al. PLoS Computational Biology
- Recent advances in the development of NS5B polymerase inhibitors for the treatment of hepatitis C virus infection
- (2009) Pierre L Beaulieu EXPERT OPINION ON THERAPEUTIC PATENTS
- Resistance to Direct Antiviral Agents in Patients With Hepatitis C Virus Infection
- (2009) Christoph Sarrazin et al. GASTROENTEROLOGY
- Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection
- (2009) Christophe Hézode et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection
- (2009) John G. McHutchison et al. NEW ENGLAND JOURNAL OF MEDICINE
- Selected Replicon Variants with Low-Level In Vitro Resistance to the Hepatitis C Virus NS5B Polymerase Inhibitor PSI-6130 Lack Cross-Resistance with R1479
- (2008) S. Ali et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Recent progress in the development of selected hepatitis C virus NS3·4A protease and NS5B polymerase inhibitors
- (2008) A KWONG et al. CURRENT OPINION IN PHARMACOLOGY
- Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients
- (2008) Thomas Kuntzen et al. HEPATOLOGY
- Why are there different dynamics in the selection of drug resistance in HIV and hepatitis B and C viruses?
- (2008) V. Soriano et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- 844 GENOTYPIC ANALYSIS OF HCV NS5B VARIANTS SELECTED FROM PATIENTS TREATED WITH VCH-759
- (2008) O. Nicolas et al. JOURNAL OF HEPATOLOGY
- Natural Prevalence of Hepatitis C Virus Variants with Decreased Sensitivity to NS3·4A Protease Inhibitors in Treatment‐Naive Subjects
- (2008) Doug J. Bartels et al. JOURNAL OF INFECTIOUS DISEASES
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started